SCHEMBL9935756

SCHEMBL9935756

O=C(CBr)NCCc1nc2c(N3CCOCC3)nc(Cl)nc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.37
HDAC1 Q13547 4/20 0.35
HDAC2 Q92769 2/20 0.35
P2RX3 P56373 2/20 0.34
AKT1 P31749 3/20 0.33
PIK3CD O00329 3/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
MAPK1 P28482 1/20 0.33
BRCA1 P38398 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NT5E P21589 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9936757 0.81 SMN1; SMN2 (0.37) HDAC1KDM4ECYP3A4
SCHEMBL9938207 0.80 SMN1; SMN2 (0.34) HDAC1KMT2ANT5E
SCHEMBL9936656 0.78 SLC29A1 (0.41) HDAC1P2RX3AKT1PIK3CDPIK3CA
SCHEMBL25391517 0.77 SMN1; SMN2 (0.38) HDAC1P2RX3PIK3CAKMT2ANT5E
SCHEMBL9935751 0.76 HDAC1 (0.35) HDAC1HDAC2P2RX3NT5E
SCHEMBL25390708 0.75 HPGD (0.42) HDAC1P2RX3PIK3CDPIK3CBPIK3CG
SCHEMBL31339118 0.74 PIM1 (0.40) HDAC1PIK3CAPIK3CBMEN1MAPK1
SCHEMBL25734588 0.74 PIM1 (0.40) HDAC1PIK3CAPIK3CBMEN1MAPK1
SCHEMBL19946533 0.74 HDAC1 (0.38) HDAC1P2RX3AKT1PIK3CDPIK3CA
SCHEMBL18123334 0.74 POLB (0.38) HDAC1P2RX3PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651951-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2013-10-23 EP disclosed
WO-2012082997-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA-ROCHE AG (CH) 2012-06-21 WO disclosed